Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(2):94-95; doi:10.1093/jnci/92.2.94
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Folkman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Folkman, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 2, 94-95, January 19, 2000
© 2000 Oxford University Press


EDITORIALS

Incipient Angiogenesis

Judah Folkman

Correspondence to: Judah Folkman, M.D., Children's Hospital, Hunnewell 103, 300 Longwood Ave., Boston, MA 02115 (e-mail: foss@hub.tch.harvard.edu).

The hypothesis that tumor growth is angiogenesis dependent (1,2) was first proposed in 1971 based on observations that expansion of a tumor mass was limited in the absence of angiogenesis. Since then, considerable experimental supporting evidence for this concept has been assembled from inhibition of angiogenesis by the following observations: 1) mechanical separation of tumor cells from their nearest vascular bed (3), 2) blockade of tumor-derived angiogenic factors (4), 3) administration of angiogenesis inhibitors (5), 4) blockade of endothelial receptors for angiogenic factors (6), 5) endogenous production of angiogenesis . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
E. Y. Lin, J.-F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D. A. Grzesik, H. Qian, X.-n. Xue, and J. W. Pollard
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Cancer Res., December 1, 2006; 66(23): 11238 - 11246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Quillen, G. C. Haslam, H. S. Samra, D. Amani-Taleshi, J. A. Knight, D. E. Wyatt, S. C. Bishop, K. K. Colvert, M. L. Richter, and P. A. Kitos
Ectoadenylate Kinase and Plasma Membrane ATP Synthase Activities of Human Vascular Endothelial Cells
J. Biol. Chem., July 28, 2006; 281(30): 20728 - 20737.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. Bullitt, P.A. Wolthusen, L. Brubaker, W. Lin, D. Zeng, and T. Van Dyke
Malignancy-Associated Vessel Tortuosity: A Computer-Assisted, MR Angiographic Study of Choroid Plexus Carcinoma in Genetically Engineered Mice
AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 612 - 619.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Mae, T. P. O'Connor, and R. G. Crystal
Gene Transfer of the Vascular Endothelial Growth Factor Receptor flt-1 Suppresses Pulmonary Metastasis Associated with Lung Growth
Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. J. Varghese, L. T. MacKenzie, A. C. Groom, C. G. Ellis, A. F. Chambers, and I. C. MacDonald
Mapping of the functional microcirculation in vital organs using contrast-enhanced in vivo video microscopy
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H185 - H193.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. Posey, T. C. Ng, B. Yang, M. B. Khazaeli, M. D. Carpenter, F. Fox, M. Needle, H. Waksal, and A. F. LoBuglio
A Phase I Study of Anti-Kinase Insert Domain-containing Receptor Antibody, IMC-1C11, in Patients with Liver Metastases from Colorectal Carcinoma
Clin. Cancer Res., April 1, 2003; 9(4): 1323 - 1332.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. N. Coleman, J. B. Mitchell, and K. Camphausen
Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm?
J. Clin. Oncol., February 1, 2002; 20(3): 610 - 615.
[Full Text] [PDF]


Home page
FASEB J.Home page
F. TOSETTI, N. FERRARI, S. DE FLORA, and A. ALBINI
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
FASEB J, January 1, 2002; 16(1): 2 - 14.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Mancuso, A. Burlini, G. Pruneri, A. Goldhirsch, G. Martinelli, and F. Bertolini
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
Blood, June 1, 2001; 97(11): 3658 - 3661.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. L. Moser, D. J. Kenan, T. A. Ashley, J. A. Roy, M. D. Goodman, U. K. Misra, D. J. Cheek, and S. V. Pizzo
Endothelial cell surface F1-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin
PNAS, May 24, 2001; (2001) 131067798.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. L. Moser, D. J. Kenan, T. A. Ashley, J. A. Roy, M. D. Goodman, U. K. Misra, D. J. Cheek, and S. V. Pizzo
Endothelial cell surface F1-FO ATP synthase is active in ATP synthesis and is inhibited by angiostatin
PNAS, June 5, 2001; 98(12): 6656 - 6661.
[Abstract] [Full Text] [PDF]